FGF‐FGFR signaling dysregulation is reported in a wide range of cancers, specifically the FGF19‐FGFR4 pathway plays a pivotal role in cancer initiation and progression.7, 9, 42, 43. The gene discussed is FGF19; the disease is cancer.